DARTRAX

Welcome to the Brand page for “DARTRAX”, which is offered here for Pharmaceuticals to treat inflammatory disorders, and diseases of the immune system, for parenteral administration;.

Its status is currently believed to be active. Its class is unavailable. “DARTRAX” is believed to be currently owned by “SmithKline Beecham plc.”


Owner:
SMITHKLINE BEECHAM PLC.
Owner Details
Description:
Pharmaceuticals to treat inflammatory disorders, and diseases of the immune system, for parenteral administration;
Categories: PHARMACEUTICALS TREAT INFLAMMATORY DISORDERS